Comparison of the effects of the alpha-2 agonists detomidine, romifidine and xylazine on nociceptive withdrawal reflex and temporal summation in horses.

The research study compares the effects of three alpha-2 agonists, detomidine, romifidine and xylazine, on pain responses in horses. The study reveals that all three drugs have a significant impact on reducing pain responses in horses, with some variations in duration of action.

Objective of the Study

• The main aim of this study was to examine and compare the antinociceptive (pain-blocking) effects of three different alpha-2 agonist drugs: detomidine, romifidine, and xylazine, with doses that are generally used for sedation in horses. The researchers used an objective measurement approach, utilizing nociceptive withdrawal reflex (NWR) and temporal summation models.

Study Methodology

• The study took a prospective, blinded, and randomized cross-over design approach. The subjects of the study were ten healthy adult horses of varying ages and weights.
• The researchers used electrical stimulation on the digital nerves to trigger NWR and temporal summation responses in both the left thoracic and pelvic limbs of each horse. They recorded the electromyographic reflex activity in response to this stimulation.
• The horses were then administered a single bolus dose of one of the three drugs studied: detomidine, romifidine, or xylazine. Following the administration of these drugs, the tests for NWR and temporal summation responses were repeated at various time intervals.
• The depth of sedation was also assessed at each of these time points. Additionally, any behavioural reactions to each stimulation were observed and documented.

Results and Conclusions

• The results showed that all three drugs significantly increased the current intensities needed to trigger NWR and temporal summation responses in the horses, compared to baseline measurements. This suggests that the drugs effectively reduced the horses’ sensitivity to pain.
• However, there were some differences in how long this effect lasted. Xylazine increased the NWR thresholds over baseline values for 60 minutes, detomidine for 100 minutes, and romifidine for 120 minutes. Similar variations were observed for temporal summation thresholds.
• The study concludes that detomidine, romifidine, and xylazine, when administered intravenously at sedation-equivalent doses, significantly increased NWR and temporal summation thresholds, effectively reducing pain responses in horses. However, the duration of this effect varied across the three drugs.